Role of TSP-5/COMP in Pseudoachondroplasia
- 30 June 2004
- journal article
- review article
- Published by Elsevier BV in The International Journal of Biochemistry & Cell Biology
- Vol. 36 (6), 1005-1012
- https://doi.org/10.1016/j.biocel.2004.01.011
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plateJournal of Orthopaedic Research, 2004
- Efficacy of growth hormone therapy for patients with skeletal dysplasiaJournal of Bone and Mineral Metabolism, 2003
- Correlation of cartilage oligomeric matrix protein (COMP) levels in equine tendon with mechanical properties: a proposed role for COMP in determining function‐specific mechanical characteristics of locomotor tendonsEquine Veterinary Journal, 2002
- Disease-causing Mutations in Cartilage Oligomeric Matrix Protein Cause an Unstructured Ca2+ Binding DomainPublished by Elsevier BV ,2002
- Δ 469 mutation in the type 3 repeat calcium binding domain of cartilage oligomeric matrix protein (COMP) disrupts calcium bindingCell Calcium, 2000
- Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runnersOsteoarthritis and Cartilage, 2000
- A Cartilage Oligomeric Matrix Protein Mutation Associated with Pseudoachondroplasia Changes the Structural and Functional Properties of the Type 3 DomainPublished by Elsevier BV ,2000
- Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudochondroplasia musculoskeletal tissuesMatrix Biology, 1998
- Natural history study of pseudoachondroplasiaAmerican Journal of Medical Genetics, 1996
- Intracellular features of type II procollagen and chondroitin sulfate proteoglycan synthesis in chondrocytesJournal of Cellular Biochemistry, 1985